Brought by three pediatric physician practices, the lawsuit claimed that physicians, medical practices, vaccine distributors/wholesalers, and health systems that bought Menactra directly from Sanofi paid inflated prices for quadrivalent meningococcal vaccines due to Sanofi’s alleged anticompetitive conduct.
Eligibility Requirements
Eligibility Requirements: All persons or entities in the United States and its territories that purchased Menactra directly from Sanofi Pasteur Inc. or its divisions, subsidiaries, predecessors, or affiliates (e.g., VaxServe, Inc.).
